Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: A meta-analysis of 15 randomized controlled trials

BACKGROUND: The prophylactic efficacy of statin pretreatment for the prevention of contrast-induced nephropathy (CIN) in patients undergoing coronary angiography (CAG) or percutaneous coronary intervention (PCI) remains controversial. The aim of the study was to perform a meta-analysis of randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Min, Yang, Shicheng, Fu, Naikuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502163/
https://www.ncbi.nlm.nih.gov/pubmed/28682890
http://dx.doi.org/10.1097/MD.0000000000007384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502163/
https://www.ncbi.nlm.nih.gov/pubmed/28682890
http://dx.doi.org/10.1097/MD.0000000000007384

Ejemplares similares